Pharmaceutical US lobby group Pharmaceutical Research and Manufacturers of America (PhRMA) revealed that member companies, thanks to President Trump’s new tax law and regulatory streamlining, are investing $500 billion in new USA-based manufacturing and infrastructure, injecting $1.2 trillion into the US economy and creating over 100,000 new jobs, including at least 25,000 direct biopharmaceutical jobs. 7 October 2025